UK markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.2150-0.0550 (-1.29%)
As of 03:15PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.17-0.14-0.55-0.31
Low estimate-0.19-0.17-0.64-0.65
High estimate-0.15-0.12-0.35-0.1
Year ago EPS0.14-0.35-0.93-0.55
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate16.45M18.17M72.76M99.09M
Low estimate15.29M15.72M61.69M67.9M
High estimate18.54M21.75M80M116.11M
Year ago sales42.39M12.3M82.51M72.76M
Sales growth (year/est)-61.20%47.70%-11.80%36.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.22-0.33-0.27-0.21
Actual EPS0.14-0.35-0.21-0.2
Difference0.36-0.020.060.01
Surprise %163.60%-6.10%22.20%4.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.14-0.55-0.31
7 days ago-0.2-0.17-0.67-0.38
30 days ago-0.2-0.17-0.69-0.45
60 days ago-0.2-0.17-0.69-0.5
90 days ago-0.2-0.19-0.95-0.41
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4351
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesGTHXIndustrySector(s)S&P 500
Current qtr.-221.40%N/AN/AN/A
Next qtr.60.00%N/AN/AN/A
Current year40.90%N/AN/AN/A
Next year43.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A